| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 13.05. | Vicarious Surgical completes pre-clinical lab for surgical robot in hernia repair | ||
| 13.05. | Rivermark Medical brings in $20M to support FloStent device for BPH | ||
| 13.05. | Orchestra BioMed targets completed BACKBEAT enrollment by end of Q3 2026 | ||
| 12.05. | FDA Commissioner Marty Makary resigns; Trump names replacement | ||
| 12.05. | Siemens Healthineers wins FDA clearance for 6 new interventional imaging systems | ||
| 12.05. | SonoMind raises $23.5M for focused ultrasound-based depression therapy | ||
| 12.05. | The 10 largest orthopedic device companies in the world | ||
| 12.05. | Zimmer Biomet increases planned share repurchase to up to $1B by end of 2026 | ||
| 12.05. | Johnson & Johnson launches next-gen Shockwave IVL catheter | ||
| 12.05. | ViCentra launches smartphone-controlled Kaleido automated insulin patch pump system | ||
| 12.05. | Stryker deal to buy Amplitude Vascular Systems could reach up to $835M | ||
| 11.05. | Corvention earns FDA clearance for aortic valve balloon catheter | ||
| 11.05. | HeartBeam starts pilot study of on-demand 12-lead ECG patch | ||
| 11.05. | Biozen wins FDA nod for cuffless blood pressure measurement tech | ||
| 11.05. | Aurie wins FDA nod for reusable intermittent catheter system | ||
| 11.05. | HistoSonics submits Edison histotripsy tech to FDA for kidney tumors | ||
| 11.05. | Medtronic to close California site | ||
| 11.05. | Siemens Healthineers lowers 2026 outlook due to China conditions, inflation, announces leadership changes | ||
| 08.05. | FDA issues Class I recall correction for Boston Scientific pacemakers | ||
| 07.05. | Stryker completes acquisition of Amplitude Vascular Systems | ||
| 07.05. | Reprieve Cardiovascular pilot study backs heart failure system | ||
| 07.05. | Glucotrack submits long-term implantable CBGM for FDA IDE | ||
| 07.05. | Insulet CEO Ashley McEvoy to keynote at DeviceTalks Boston | ||
| 07.05. | SS Innovations demonstrates long-distance telerobotic surgery capabilities over 4,500 miles | ||
| 06.05. | Johnson & Johnson Abiomed president to keynote at DeviceTalks Boston |